APA citiranje

Yoshihama, S., Roszik, J., Downs, I., Meissner, T. B., Vijayan, S., Chapuy, B., . . . Kobayashi, K. S. (2016). NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proc Natl Acad Sci U S A.

Citação norma Chicago

Yoshihama, Sayuri, et al. "NLRC5/MHC Class I Transactivator Is a Target for Immune Evasion in Cancer." Proc Natl Acad Sci U S A 2016.

MLA citiranje

Yoshihama, Sayuri, et al. "NLRC5/MHC Class I Transactivator Is a Target for Immune Evasion in Cancer." Proc Natl Acad Sci U S A 2016.